The Message from the Congress Scientific Chair
| Post date: 2025/02/19 |
In the Name of God
The Message from the Congress Scientific Chair
It is a distinct pleasure and honor to welcome distinguished guests and esteemed colleagues to the prestigious event of 16th international and 22nd national congress on Quality Improvement in Clinical Laboratories (QILC 2025), which will be held under the esteemed auspices of the International Federation of Clinical Chemistry (IFCC) and the European Federation of Laboratory Medicine (EFLM). This congress represents a vital opportunity for us, as members of the global laboratory medicine community, to share knowledge, and explore the latest advancements that are shaping the future of our field. Our focus this year is on the dynamic interplay between the past, present, and future of laboratory medicine with a particular emphasis on the transformative power of high-throughput technologies and artificial intelligence. We are living in an era of unprecedented technological progress, and the clinical laboratory is at the forefront of this transformation. The rapid evolution of high-throughput technologies has revolutionized the way we approach laboratory testing. These powerful tools enable us to process vast quantities of samples with remarkable speed and accuracy, opening new avenues for disease detection, personalized medicine, and large-scale research. From genomics and proteomics to metabolomics and beyond, high-throughput platforms are providing invaluable insights into the complexities of human health and disease. Equally transformative is the rise of artificial intelligence in healthcare. AI algorithms, with their ability to analyze complex datasets and identify patterns that would be impossible for the human eye to detect, are poised to revolutionize diagnostics. From automated image analysis in pathology and radiology to the development of sophisticated diagnostic algorithms, AI is empowering us to make more informed decisions, improve patient outcomes, and enhance the efficiency of our laboratories. This congress will delve into the exciting intersection of these two powerful forces: high-throughput technologies and artificial intelligence. We will explore how these advancements are being applied in various disciplines within laboratory medicine, including but not limited to precision medicine, infectious disease diagnostics and cancer diagnostics. In this congress, we will have the opportunity to hear from leading experts in their respective fields, engage in stimulating discussions, and network with colleagues from around the world. We are confident that this congress will be a resounding success, providing a platform for the exchange of ideas, the forging of new collaborations, and the inspiration for future innovations. Together, we can harness the power of high-throughput technologies and artificial intelligence to improve the quality of patient care and advance the field of laboratory medicine.
Thank you for joining us. We wish you all a productive and enriching congress.
Prof. A. H. Zarnani and Dr. A. H. Naseri
Scientific Chairs
Dr. F. Shaygan
Scientific manager and co-scientific chair in international affairs
Dr. A. Shirin
Co-scientific chair in workshop affairs
View: 2204 Time(s) |
Print: 631 Time(s) | Email: 0 Time(s) |
0 Comment(s)